Story

Investing.com AI Model Flags Value Stocks With Significant Gains

ENTHMSVIIDZHZH-TWJAKOHI
Aug 25, 20262 min read
Investing.com AI Model Flags Value Stocks With Significant Gains
Text size
Background

An artificial intelligence stock-selection model has identified several value-oriented equities that subsequently delivered substantial returns, according to a report from financial markets platform Investing.com. The model flagged companies including medical technology firm Haemonetics Corp., which has since gained nearly 100%.

Reported Performance Highlights

According to the report, the platform's ProPicks AI strategies have highlighted a number of stocks that went on to post significant gains since their selection. The firm states these selections are rebalanced monthly based on its quantitative models.

Key performers cited by Investing.com include:

  • Haemonetics (NYSE:HAE): +98.75%
  • Everforth (NYSE:EFOR): +85.08%
  • Merck & Co. (NYSE:MRK): +45.23%

Investing.com also reported that its overall strategy has generated a cumulative return of +184.93% since its public launch in November 2023. The firm claims this performance outpaces the S&P 500 by more than 104 percentage points over the same period.

Rationale Behind Selections

Sample IUX Markets – In-articleAd

The report detailed the quantitative rationale its AI models used to identify two of the high-performing stocks prior to their rallies. The analysis focused on valuation metrics, profitability, and specific business catalysts.

For Haemonetics, the model reportedly identified a valuation disconnect, noting the stock traded at a forward P/E ratio of 14.9x and a PEG ratio of 0.34. This was combined with strong fundamentals, such as a 58.8% gross margin and a key supply agreement with CSL Plasma, according to the analysis.

In the case of Merck & Co., the AI flagged the pharmaceutical giant for its low P/E ratio of 13.9x and PEG ratio of 0.24. The model also cited strong earnings execution, highlighted by a 56.3% year-over-year surge in EBITDA, and the commercial momentum of its drug pipeline, including Keytruda and Winrevair.

Model Methodology

Investing.com states its proprietary AI system assesses thousands of global stocks each month. The process involves analyzing over 15 years of financial data across more than 150 quantitative models to identify equities with projected medium-term upside potential. The strategies are then rebalanced monthly to add new opportunities and remove stocks that no longer meet the selection criteria.

Read next

More on Stocks
Back to latest news

LATEST